Table 4. Bio-evaluation of compounds 3a–3o and 4a–4k.

Compound	IC50 (μM)
	MOLM-13	MV4-11
3a	28.99 ± 7.07	44.17 ± 1.34
3b	34.80 ± 3.47	32.05 ± 3.97
3d	84.35 ± 8.19	92.52 ± 6.20
3e	24.44 ± 9.96	32.28 ± 5.21
3h	30.29 ± 1.98	87.34 ± 1.81
3i	31.74 ± 3.13	87.75 ± 0.62
3l	13.24 ± 0.41	10.63 ± 0.44
3m	19.79 ± 1.57	19.91 ± 1.68
3n	8.53 ± 0.34	9.73 ± 0.17
4a	86.57 ± 5.43	43.82 ± 1.48
4b	42.41 ± 4.38	30.80 ± 1.15
4c	10.64 ± 0.40	41.79 ± 8.01
4e	17.95 ± 0.86	8.19 ± 1.87
4f	19.94 ± 1.06	18.69 ± 2.38
4g	10.43 ± 0.37	13.54 ± 3.65
4i	44.19 ± 3.97	72.58 ± 9.05
4j	47.07 ± 5.95	84.39 ± 6.86
Cabozantinib	0.045	0.003